Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
celgene
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
intercept pharmaceuticals
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
4d molecular therapeutics
abbvie
acne
activism
acute hepatic porphyria
agenus
alnylam pharmaceuticals
What
bio
3
×
race
3
×
disease
drug
gene
liver
roundup
advanced
alnylam’s
approval
approved
bff
companies
conference
create
crispr
deals
devoted
diagnostic
digital
diseases
easl
editing
epidemic
fatty
fda
fix
form
frenzied
growing
heats
high
human
kicked
known
launches
led
major
medicines
merck
Language
Current search:
race
×
bio
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
